ABSTRACT This study was conducted to determine the influence of vitamin E on the retinol binding protein (RBP) and cytochrome p450 family 26 subfamily A polypeptide 1 (CYP26A1), which are specific transporters and catabolic enzymes of vitamin A, respectively. In the in vivo experiments, a total of 450 laying hens was fed 5 levels of vitamin E (0, 20, 80, 320, and 1,280 IU/kg of feed) supplementation. For the in vitro assays, hepatocytes from laying hens were cultured in 4 levels of α-tocopherol (0, 10, 50, and 100 μM). High dietary vitamin E increased the concentration of vitamin A in liver (P < 0.05). The RBP and its mRNA expression in liver and hepatocytes were markedly inhibited by dietary vitamin E (320 and 1,280 IU/kg) and α-tocopherol (100 μM) in culture medium (P < 0.05). However, CYP26A1 and its mRNA expression were not affected by vitamin E in both liver and hepatocytes (P > 0.05). The results indicate that excessive vitamin E could increase the concentration of vitamin A in liver by inhibiting RBP synthesis in hepatocytes. 
INTRODUCTION
Vitamins E and A are essential fat-soluble vitamins that play important roles in several similar basic biological functions, such as reproduction and immune system regulation (Sheridan and Beck, 2008; Long et al., 2011) . Previous studies demonstrated that with the elevation of dietary vitamin E (0-1,000 IU/kg of diet) in laying hens, the level of vitamin A in liver significantly increased 16.3-folds, while it decreased by 27.4% in yolk and remained unchanged in plasma (Sklan, 1983; Sünder et al., 1999; Sünder and Flachowsky, 2001) . Napoli et al. (1984) pointed out that 100 μM tocopherol inhibited retinol hydrolase activity by about 50% in rat liver. This may be one reason why dietary vitamin E increased vitamin A in mammalian liver. However, retinol hydrolase has not been identified in poultry.
Recently, researchers have gained more information about the transport and catabolism of vitamin A. Zanotti et al. (2001) found that retinol binding protein (RBP) was a specific transport protein of vitamin A in the plasma of chicken, and they found that the liver was the major organ of RBP synthesis and secretion. White et al. (1997) were the first to identify the cytochrome P450 family 26 subfamily A polypeptide 1 (CYP26A1), which belongs to the cytochrome P450 (CYP450) super family, involved in catabolism of vitamin A. This CYP26A1 can oxidize retinoic acid into its inactive forms, 4-oxo-retinoic acid and 4-hydroxyretinoic acid, which are excreted through the digestive system (Ray et al., 1997; Swindell et al., 1999; Lampen et al., 2001; Perlmann, 2002) . However, no study provides insight into the possibility that vitamin E might influence vitamin A by regulating RBP and CYP26A1. The current investigation was designed to elucidate the effects of vitamin E on increasing vitamin A concentrations in liver after dietary administration in vivo or their direct addition in vitro.
MATERIALS AND METHODS

Chemicals
dl-α-Tocopheryl acetate (purity 50%) and α-tocopherol (purity 96%) were purchased from Guobang Pharmaceutical Chemical Group Co. Ltd. (Zhejiang, China) and Sigma-Aldrich Co. (Shanghai, China), respectively. E (dl-α-tocopheryl acetate) on concentrations of vitamin A in liver, yolk, and plasma of laying hens and RBP and CYP450 in tissues. The mRNA expression of RBP and CYP26A1 were also detected in tissues. All experimental procedures were approved by the Beijing Administration Office of Laboratory Animals. Four hundred and 50 Jing Hong hens (a brown-egg laying hen), 24 wk of age, with similar BW (1.47 ± 0.10 kg) and laying rate (70 ± 5%) were randomly divided into 5 groups, which were assigned to one control group and 4 treatment groups. Each group had 6 replicates with 15 birds. Feed and water were supplied ad libitum, and the hens received 16 h of light/d throughout the course of this experiment. The control group was fed a diet based on corn-soybean meal that was formulated to fulfill all nutrient requirements for laying hens (NRC, 1994) , but vitamin E was not included in the vitamin/mineral premix. The raw material composition and nutritive value of the diets are shown in Table 1 . From this basal diet, 4 diets containing different concentrations of vitamin E (20, 80, 320, or 1,280 IU/kg of diet) were prepared. The analyzed concentration of vitamin E and A in each group is presented in Table 2 . Prior to the feeding trial, all birds were fed the basal diet for 2 wk, and the experiment lasted for 8 wk.
Experiment 2. This experiment was carried out to investigate the influence of α-tocopherol on RBP and CYP26A1 mRNA expression in hepatocytes from laying hens. The laying hens were fed vitamin E nonsupplemental diets, as described in experiment 1. The methods and materials used in hepatocyte isolation and culture procedures were based on the literature, with some modifications (Fraslin et al., 1992) . The tubal vein, pancreaticoduodenal vein, and posterior mesenteric vein in the distal end were ligated before liver perfusion. The culture conditions were identical with normal hepatocytes (Sato et al., 2005) . The medium was William's medium E (Sigma, Shanghai, China), containing 2 mM glutamine (Sigma), 100 U/mL of penicillin (Sigma), 100 μg/mL of streptomycin (Sigma), 1 μM human insulin (Sigma), 1 μM dexamethasone (Sigma), 10 μg/mL of human transferrin (Sigma), and 10 μg/mL of ascorbic acid (Sigma). The initial medium was replaced with α-tocopherol (0, 10, 50, and 100 μM) supplemented William's medium E (serum-free) after 5 h in culture. The experiment was repeated 4 times.
Sample Collection and Assay
In experiment 1, egg production and egg weights were measured daily throughout the experimental period. Feed consumption and feed conversion ratio were measured in each week. Eggs in each replicate were collected and the shell hardness, Haugh units, yolk color, shell thickness, and albumen height were tested each 2 wk. Vitamin E and vitamin A in the diets were determined at the beginning of the experiment. At the end of the 4th and the 8th weeks, all egg yolks were collected, and one hen from each replicate was randomly selected and slaughtered to get liver and plasma samples to determine vitamin E and vitamin A using HPLC (e2695, Waters Alliance, Vaughn, WA) described by Sünder and Flachowsky (2001) . Analysis of RBP in liver and plasma was carried out with commercial chicken ELISA kits (R and D Systems China Co. Ltd., Shanghai, China). The ELISA was performed according to the manufacturer's instructions and the description of Mao et al. (1996) . Briefly, 5 g of liver samples were neutralized by adding 15 mL of 1 mol/L PBS (pH 7.4) and homogenized by grinders. Each specimen (liver homogenate or plasma) was centrifuged (3,000 × g for 20 min at 4°C), and supernatants were collected. The polystyrene microtiter plate was coated with anti-RBP antibody overnight at 4°C. Diluted RBP calibrator solution or samples, antibody-enzyme conjugate, and o-phenylenediamine substrate were added separately to each well of the plate during each interval. The plate was incubated for 30 min at 37°C and washed 5 times with PBS containing 3.3 g/L of BSA. The plate was then agitated for 15 min at 37°C. The reaction was stopped with 50 μL of 2 mol/L solution of sulfuric acid, and the absorbance of the mixture was measured at 450 nm with a microplate reader (MK3; Thermo Scientific, Waltham, MA). Each liver and plasma sample was tested in duplicate. The hepatic microsome was prepared by differential velocity centrifugation (Rifkind et al., 1982) , and the CYP450 was measured as Yang and Jiang (2006) described. Analysis of RBP and CYP26A1 expression at the mRNA level was carried out by semiquantitative PCR according to the literature (Morris and Davila, 1996; Meadus, 2003) . Total RNA was extracted from 100 mg of livers from laying hens with the total RNA isolation (TRIzol) reagent (Tiangen Biotech, Beijing, China), following the manufacturer's instructions. First-stand cDNA was synthesized with M-MLV reverse transcriptase from Promega (Fitchburg, WI), according to the manufacturer's instructions. To amplify the conserved region of RBP, CYP26A1, and GAPDH (housekeeping gene) cDNA, 3 pairs of primers were designed according to the conserved regions of RBP, CYP26A1, and GAPDH genes from gallus using the DNAssist 2.0 software (H. Patterton and S. Graves). The primers of RBP were L1 (5′-CTTCAATAACTGGGATGTCTG-3′) and L2 (5′-GGTCTATCTGCCTTTGTCTAAC-3′). The primers of CYP26A1 were L1 (5′-ATGGAGCA-CACACAGGGTAAT-3′) and L2 (5′-GTTGAACTC-GTCCTTGTCGGT-3′). The primers of GAPDH were L1 (5′-AGGGCACTGTCAAGGCTGAG-3′) and L2 (5′-ACGCTGGGATGATGTTCTGG-3′). The PCR products were first incubated at 94°C for 5 min, and then incubated by a stepped program (94°C, 40 s; 55°C for RBP, 54°C for CYP26A1, or 56°C for GAPDH, 30 s; 72°C, 40 s) for 27 cycles, and by an extension at 72°C for 5 min. The PCR products were about 240 and 423 bp long, respectively. The PCR products were separated on 2% agarose gels. The gel images were digitally captured with a Bio-Imaging system. Densitometry values were measured by the One-Dscan software (Scanalytics, Fairfax, VA). The semiquantitative PCR was repeated 3 times. In experiment 2, cells were harvested 20 min after the addition of α-tocopherol to the medium (Dixon and Goodman, 1987) . The lactate dehydrogenase activity (LDH) and total protein in the supernatant were determined with commercial diagnostic kits (Jiancheng Bio Co., Nanjing, China) and bicinchoninic acid assay (Beyotime Biotechnology Co., Haimen, China; Liu et al., 2004; Hao et al., 2010) . The content of RBP was measured as described previously. Analysis of RBP and CYP26A1 expression at the mRNA level was carried out by semiquantitative PCR as described in experiment 1, with the only modification that total RNA was extracted from the hepatocytes of laying hens.
Statistical Analysis
All data was analyzed using the one-way ANOVA (ANOVA), and means were compared by the Duncan's multiple range test (SAS Institute Inc., Cary, NC). Effects were considered significant when P < 0.05.
RESULTS
Experiment 1
No influence (P > 0.05) was observed on laying hen performance and egg quality parameters (data not shown). Mean values for the following parameters were recorded: hen-day egg production (76.2%), egg weight (62.2 g), feed intake (115 g/d), feed conversion rate (2.45 feed/egg, g/g), eggshell hardness (42.11 N/cm 2 ), Haugh unit (89.62), Roche fan color (7.1), shell thickness (0.29 mm), and albumen height (8.14 mm).
The effects of dietary vitamin E supplementation on liver, egg yolk, and plasma α-tocopherol and retinol in the 4th week and 8th week are shown in Figure 1 and Figure 2 . In the 4th week and 8th week, adding different levels of vitamin E to the diets, the contents of α-tocopherol and retinol were significantly increased (P < 0.05) in liver. In the 4th week, a significant effect of vitamin E supplementation was observed, as hens fed with the higher concentration of vitamin E had higher egg yolk α-tocopherol (P < 0.05). In the 4th week, the content of retinol in egg yolk significantly increased (P < 0.05), when dietary vitamin E supplementation reached 80 IU/kg. In the 8th week, the content of retinol in egg yolk also significantly increased (P < 0.05), when dietary vitamin E supplementation amounted to 20 and 80 IU/kg. In the 8th week, however, higher vitamin E (320, 1,280 IU/kg) supplementations significantly decreased (P < 0.05) vitamin A concentrations of egg yolk. The plasma concentration of α-tocopherol showed a maximum at a supplementation level of 1,280 IU/kg of diet, and the plasma concentration of retinol was independent of the vitamin E supply.
The content of RBP in liver and plasma at different levels of dietary vitamin E are shown in Table 3 . In the 4th week, the content of RBP in liver decreased with the increasing dietary vitamin E concentrations. When the dietary vitamin E was 1,280 IU/kg, it significantly reduced the liver RBP (P < 0.05), and compared with the control group, the content of liver RBP decreased by 28.1%. In the 8th week, the content of RBP in the 320 and 1,280 IU/kg dietary vitamin E groups was significantly (P < 0.05) decreased compared with the control group. Supplementation with vitamin E in either group had no significant effect on the plasma RBP concentration throughout the experimental period.
The relative liver weight, content of microsomal protein, and CYP450 are presented in Table 4 . No differences were observed in the 4th week and 8th week.
The mRNA expression of RBP and CYP26A1 involved in vitamin A metabolism was measured by semi-quantitative reverse-transcription PCR with cDNA from liver of laying hens (Figure 3) . A marked downregulation of RBP mRNA expression was observed in liver from the 1,280 IU of vitamin E/kg of supplementation group. The CYP26A1 mRNA expression was not affected by different vitamin E treatments.
Experiment 2
Four levels of α-tocopherol were tested by reacting with hepatocytes from α-tocopherol-depleted laying hens. The LDH activity, total protein, and RBP content were measured in the culture medium and cells after 20 min (Table 5 ). There were no differences observed in LDH activity and total protein concentration. However, when culture medium contained 100 μM α-tocopherol, RBP secretion was significantly inhibited (P < 0.05), approximately 26.9% compared with the control group.
The PCR products representing RBP and CYP26A1 from hepatocytes are shown in Figure 4 . A marked downregulation of RBP mRNA expression was observed in hepatocytes in 100 μM α-tocopherol groups, whereas CYP26A1 mRNA expression was not affected by different α-tocopherol treatments.
DISCUSSION
Consistent with our results, several studies have not found any positive (Kling and Soares, 1980; Grobas et al., 2002) or negative (Meluzzi et al., 2000; Galobart et al., 2001 ) effects on the performance and egg quality of laying hens when vitamin E was added at the same level (i.e., 1,280 mg/kg).
In our study, diets containing different vitamin E concentrations were fed to laying hens. As expected, the α-tocopherol and retinol concentrations in liver were distinctly higher after feeding excessive vitamin E. The retinol concentration of egg yolk was significantly decreased from 6.87 to 5.62 mg/kg in the 8th week, whereas α-tocopherol in the egg increased without reaching a plateau. Plasma retinol was not affected by dietary or plasma vitamin E concentrations. Similar observations were made by other groups (Sklan, 1983; Sünder et al., 1999; Sünder and Flachowsky, 2001) .
In the present study, the content of RBP and its mRNA expression in liver, plasma, and hepatocytes from laying hens were measured to determine whether vitamin E affected vitamin A, caused by RBP. The findings indicate that the concentration of RBP in plasma is not affected by excess vitamin E in the diet, but a marked decrease in liver and hepatocyte RBP synthesis would be expected to result in a higher concentration of vitamin A in liver because vitamin A cannot be excreted from the liver without RBP (Noy, 2000) . The observation that plasma RBP content was not affected may be due to the fact that extrahepatic tissues also can secrete RBP (Soprano et al., 1986; Whitman et al., 1990) , thus maintaining the RBP stability in circulatory system. Other studies have also shown that RBP can be regulated by fat-soluble vitamins. The RBP secretion from rat liver was specifically inhibited during retinol deficiency; however, when resupplying the deficient rats with retinol rapidly, its release would be specifically stimulated (Muto et al., 1972; Goodman, 1984) . Muto et al. (1972) reported that plasma RBP declined from 50 ± 4 μg/mL to 13 ± 2 μg/mL in vitamin A-deficient rats during 75 d, and a very rapid increase in RBP level from 14 to 56 μg/mL was observed in 5 h when 24 μg of vitamin A was administrated orally to deficient rats on d 53. In contrast, addition of exogenous retinol did not appear to influence RBP secretion in normal rat hepatocytes (Dixon and Goodman, 1987) . In our study, both in vivo and in vitro experiments have shown that excessive vitamin E (1,280 IU/kg of dl-α-tocopheryl acetate supplementation in diet and 100 μM α-tocopherol in cell medium) inhibit the synthesis of RBP in liver and hepatocytes. The observations that the activity of LDH and the content of total protein are not affected implies that RBP is specifically decreased by vitamin E because no significant change of LDH activity and total protein content indicates that all cells are in the similar and comparable conditions. Although semiquantitative reverse-transcription PCR is not the most accurate method, it is useful in determining qualitative and quantitative gene expression (Meadus, 2003; Kuo and Chang, 2007) . We use this method to verify the effects of vitamin E on RBP and CYP26A1 mRNA expression according to the literature (Morris and Davila, 1996; Meadus, 2003) . Our results first indicate that the RBP mRNA expression in liver and hepatocytes is downregulated by 1,280 IU/ kg of vitamin E supplication and 100 μM α-tocopherol, respectively. Therefore, we conclude that RBP mRNA expression is inhibited by excessive vitamin E supplementation.
Megadoses of vitamin E do not lower the contents of hepatic microsomal protein, CYP450, and CYP26A1 mRNA expression in liver and hepatocytes from laying hens. In contrast, CYP26A1 expression in normal human neonatal foreskin keratinocytes is extremely sensitive to both exogenous retinol acid and increased endogenous retinol acid due to CYP26 inhibition (Pavez-Loriè et al., 2009 ). Mustacich et al. (2009) demonstrated that increased hepatic α-tocopherol modulates its own concentrations through increasing the xenobiotic metabolism. They fed mice with a 1,000 IU vitamin E supplementation diet for 4 mo; in this group, catabolic gene expression of P450 oxidoreductase and CYP3A11 increased 1.6-and 4-fold, respectively, com- pared with the control group. Thus, we suggest that vitamin E may not influence the catabolism of vitamin A.
In summary, our study indicates that vitamin E increases the level of vitamin A in liver of laying hens. Particularly, we demonstrate that vitamin E in 320 and 1,280 IU/kg of diet or 100 μM medium inhibits RBP synthesis, but does not affect CYP26A1 mRNA expression in liver and hepatocytes.
